AstraZeneca carving out antibiotic R&D into separate firm
February 27, 2015 at 02:01 AM EST
LONDON, Feb 27 (Reuters) - Drugmaker AstraZeneca has decided to carve out its early-stage antibiotic research by creating a stand-alone subsidiary company, as it sharpens its focus on other therapy areas.